Chitosan nanoparticles for urinary tract infections caused by E. coli
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a new nanoparticle treatment can fight E. coli bacteria that cause urinary tract infections (UTIs). If you have a UTI caused by E. coli and haven't taken antibiotics recently, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a urinary tract infection (UTI) diagnosed by a doctor
- Your urine culture shows a high number of E. coli bacteria (at least 100,000 per milliliter)
- You have not taken any antibiotics in the last 2 to 3 days
- You are male or female, of any age
- Your urine sample is collected properly and not contaminated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to use special tests (called integrons) to help doctors decide if they can safely use fewer strong antibiotics for urinary tract infections that are resistant to common treatments. It is for people in the hospital who have a resistant infection and may help reduce side effects and prevent more resistance.
This trial tests if a special infection control program can reduce infections in patients with urinary catheters in the hospital. It may help prevent catheter-related infections during your stay.
This study collects and studies bacteria (E. coli) found in urine from people with urinary tract infections, including those with repeat infections. It may help improve how doctors understand these infections and choose better future treatments.
This study looks at bacteria (E. coli) in patients with catheter-related urinary tract infections. It aims to understand the types and genetics of the bacteria to improve treatment.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This trial compares a new treatment approach—high-dose antibiotics combined with methenamine hippurate—against standard care for women with chronic urinary tract infections (UTIs). It aims to find if the combination works better at relieving persistent symptoms like pain and frequent urination.
Hear when a new Urinary Tract Infections (UTIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.